This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Musk files reply for striking OpenAI defenses in US suit over nonprofit status

( July 17, 2025, 22:31 GMT | Official Statement) -- MLex Summary: Elon Musk and his xAI filed a reply in support of a motion to strike 55 affirmative defenses offered by OpenAI and its CEO, Sam Altman, to Musk’s lawsuit over the move of OpenAI to for-profit status. “OpenAI’s opposition tacitly concedes the fundamental deficiencies plaintiffs identified in their motion to strike. The proposed amended answer removes all thirty-seven negative defenses and attempts to add factual detail to the remaining affirmative defenses. This complete overhaul— eliminating 67 percent of the defenses and only now attempting to substantiate the remaining ones— effectively confirms plaintiffs’ argument: the original answer failed to provide fair notice, fell far short of the Twombly/Iqbal standard, and improperly included duplicative and confusing negative defenses,” the brief said.See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections